Skip to main content
PLOS One logoLink to PLOS One
. 2026 May 13;21(5):e0348023. doi: 10.1371/journal.pone.0348023

Quantitative genetic analysis of respiratory function and related traits in Bulldogs, French Bulldogs and Pugs

Joanna Jadwiga Ilska 1,*, Fern McDonnell 1, Jane Frances Ladlow 2,3
Editor: Adolfo Maria Tambella4
PMCID: PMC13170967  PMID: 42127146

Abstract

Brachycephalic Obstructive Airway Syndrome (BOAS) is a common health issue in brachycephalic breeds like Bulldogs, French Bulldogs, and Pugs, linked to their distinctive skull morphology. Despite its prevalence, the genetic basis of respiratory dysfunction in these breeds remains poorly characterised. To enable selection against BOAS, the Respiratory Function Grading Scheme (RFGS) was established in 2019, where respiratory function of dogs considered for breeding is tested via a standardised exercise test. Here, we analysed RFGS data from over 4,000 dogs, alongside pedigree records, to estimate heritability of respiratory function and assess RFGS participation across the UK Royal Kennel Club registered populations of the three extreme brachycephalic breeds. Moderate heritability estimates for RFGS grade (0.21–0.49), and nostril stenosis (0.31–0.39), with significant genetic correlations between the traits indicate that within-breed selective breeding can improve respiratory health. These findings support the feasibility of breeding programs targeting respiratory function. Implementing such strategies, alongside increased health screening participation, may help mitigate BOAS prevalence and enhance welfare in these popular breeds.

Introduction

Brachycephalic Obstructive Airway Syndrome (BOAS) is widely regarded as one of the highest priority conformation-related disorders in canine health [1–7]. The condition is causally linked to brachycephalic skull morphology, characterised by a shortened muzzle, wide head and thick neck [8–10]. Clinically, BOAS presents as noisy breathing (stridor and stertor), inspiratory dyspnoea, increased inspiratory effort, regurgitation, heat and exercise intolerance, sleep-disordered breathing, cyanosis, collapse and, in extreme cases, death [8,11]. Although occasionally observed in juvenile dogs (8,12), BOAS is typically diagnosed by three to four years of age [12,13]. While owners report that the condition progresses with age [14], several studies have found no significant association between BOAS severity and age in adults [10,11,15–17]. In contrast, a consistent link exists between BOAS and body condition score (BCS), with obese dogs at higher risk of developing the disease, and with greater clinical severity [9–11,16,17].

Although the presenting signs of BOAS were recorded in sources from around 1900 [18], and it was formally described in the1940s [19], its prominence has increased sharply since 2000, coinciding with the surge in global popularity of Bulldogs, French Bulldogs and Pugs – the breeds most frequently affected [9,16,20]. Reported prevalence of BOAS in those breeds varies widely, from as low as 3.5% [21] to over 60% [17,22], depending on diagnostic criteria and sampling approach. Owner-reported estimates likely understate the prevalence, as clinical signs – such as noisy breathing or exercise intolerance – are often normalised as “typical for the breed” [11,23–25]. Conversely, clinic-based data may over-represent affected dogs because healthy brachycephalic dogs are presented less frequently for routine care [26]. Nearly one in six dogs in the UK is currently brachycephalic [27]. This rapid rise in ownership forms an important backdrop to the current welfare debate. Aesthetic appeal remains the principal driver of demand, while health and welfare considerations are often secondary [26,28–30]. Combined with the high prevalence of BOAS, this disconnect between owner perception and clinical reality has been described by some authors as the “brachycephalic crisis” [31].

In response, several interventions have been proposed, including amending breed standards to remove language promoting exaggerated conformation [4,9,23,28,32–34]. In the UK, breed standards for all three breeds were substantially revised in 2009 and iteratively further amended since in an effort to discourage exaggeration (A. Skipper, personal communication). However, the impact of these changes on the overall population remains unclear. Outcrossing programmes have also been proposed to reintroduce more moderate skull shapes [9,33]. The Netherlands attempted to legislate this strategy in 2020 by banning breeding of dogs with a craniofacial ratio (CFR) below 0.3 [6]. Although a recent survey of primarily non-brachycephalic dog owners showed a preference for more moderate appearance [35], previous surveys across the UK, Denmark, and Germany show strong continuity of breed preference among brachycephalic owners [25,26,30,34,36,37]. This likely poses a barrier to population-wide morphological change through outcrossing.

An alternative route for reducing incidence of BOAS involves within-breed selective breeding programmes. A key consideration for such programmes is identifying the phenotype that offers the greatest potential for effective selection. Although CFR captures an important aspect of brachycephalic conformation, it is unlikely to be useful for within-breed selection due to limited phenotypic variation [9,33], and its consistently low predictive value for BOAS [10,17,38,39], as well as low reproducibility [17]. Despite low average CFR values, ranging from 0.11 (SD 0.04) in Pug to 0.16 (SD 0.04) in French Bulldog [17], not all dogs in those breeds are clinically affected, indicating additional risk factors. To date, no estimates of genetic correlations between CFR and BOAS have been published.

These limitations highlight the need for phenotype assessments that capture functional consequences of conformation rather than conformation itself. Objective assessments using whole-body plethysmography (WBBP) accurately characterise respiratory function [11], but the method’s cost and technical requirements preclude population-level use. An efficient pre-breeding screening protocol must be accurate, minimally invasive, quick to administer, inexpensive and widely accessible. Consequently, several exercise-based functional grading systems have been developed that quantify respiratory distress through pre- and post-exercise auscultation [11,15,16,38–42].

The Royal Kennel Club (RKC), in collaboration with the University of Cambridge, introduced the Respiratory Function Grading Scheme (RFGS) in 2019, following formal validation of an exercise and auscultation method against WBBP [11,16,42]. Validation studies demonstrated strong correlations between post-exercise clinical grades and WBBP-derived indices [16]. The exercise challenge used in RFGS reveals cases that may be underestimated at rest, highlighting the advantage of dynamic assessment [11]. The RFGS assigns functional grades from 0–3, with grades 0–1 considered clinically unaffected and grades 2–3 indicating BOAS of increasing severity. High inter-assessor repeatability and the clear differentiation between unaffected and affected dogs further support the method’s robustness [42]. The RFGS therefore provides a practical, validated system suitable for large-scale screening and for investigating phenotypic severity and heritability of BOAS traits. Full RFGS test procedures and breeding guidance are provided in S1 File.

Current breeding recommendations under RFGS were based on pragmatic selection against a highly prevalent trait presumed to be heritable, despite limited information on its genetic architecture. Several genes have been linked to brachycephalic skull morphology, e.g., SMOC2 – which accounts for 36% of phenotypic variation in facial length [43], BMP3 [44], or DVL2 [45,46]. However, these variants are nearly fixed in extreme brachycephalic breeds [44,45], suggesting additional genetic or morphologic contributors to BOAS. A genetic basis is nonetheless strongly supported: two currently available estimates of heritability for BOAS range from 0.4 with a considerable standard error of 0.16 using mid-parent-offspring regression [47] to 0.6 (no standard error of the estimate provided) based on preliminary genome-wide association study of approximately 200 dogs per breed [48].

The aims of this study were to estimate the heritability of respiratory function grades in Bulldogs, French Bulldogs and Pugs, and to evaluate the potential for within-breed selection against BOAS in UK populations registered with the RKC. To achieve this, we analysed two complementary datasets: routine pre-breeding RFGS records from the largest cohort studied to date, and a secondary research dataset with additional phenotypes. Finally, we quantified participation in the RFGS across subpopulations, distinguishing between show-bred dogs and those bred outside the breed standard (based on coat colour), to evaluate the potential for improving upper respiratory health in these three popular brachycephalic breeds.

Materials and methods

Data

Data used in the analyses included 1) grades collected through the RFGS on Bulldog, French Bulldog and Pug; 2) additional research data collected on some of the RFGS tested dogs in the three breeds, 3) complete pedigree records for the three breeds as available in the electronic database of the RKC. The data is available in S3–S8 Tables.

The RFGS dataset included a total of 4301 grades, of which 1474, 1917 and 900 were recorded on Bulldog, French Bulldog and Pug respectively. The dataset included identification of the dog (RKC registration number, RKC registered name, microchip and RKC internal dog reference number), dog’s date of birth, RFGS test date, assessor and grade recorded on a scale from 0 to 3 as described previously [42]. The assessor identifier was missing for 583 grades, and these were assigned unique dummy variables. For dogs with multiple grades available, the number of days between first and last test was calculated, as well as grade progression classified as improved, same, or worsened. Although RFGS was officially launched in 2019, there were 73 grades collected during Scheme development between 2015 and 2018.

RFGS grades were converted to binary BOAS status following [17] for summary reporting, with grades 2 and 3 treated as clinically affected (BOAS+). Date of birth (DOB) and date of test (DOT) were converted to ordinal format then scaled and centred, and age at testing was calculated in days (scaled and centred), with age in completed years used for descriptive summaries. Year of birth and year of test were extracted from DOB and DOT, and centred.

For genetic analyses, the ordinal RFGS grades were transformed to presumed underlying liability scale using the threshold model [49] as shown in Eq 1.

yj=ϕ(zj−1)− ϕ(zj)Φ(zj)−Φ(zj−1), zj=Φ−1(∑i=1jpi) (1)

Where yj is the expected value of underlying liability distribution for individuals with grade j, pj is the observed proportion of grade j, ϕ() and Φ() are the standard normal probability density and cumulative distribution functions respectively.

The additional research dataset included some of the RFGS dogs, with variable levels of recording per individual and included: 2248 body weight measurements (BW, kg), 3084 body condition scores (BCS) on a 9-point scale with increasing scores reflecting increasing body fat content [50], and 3133 nostril stenosis (STEN) graded on a 4-point scale of open, mild, moderate and severe stenosis, as described previously [17]. A binary obesity variable was generated, classifying dogs with BCS ≥ 7 as obese. STEN grades were converted to underlying liability scale as previously shown for RFGS grade (Eq 1) for the genetic analyses, and to binary stenotic nares status for summary reporting, with dog treated as affected, i.e., presenting with stenotic nares, when the STEN grade was moderate or severe [17].

Pedigree included dog’s sex, date of birth, coat colour, studbook number (SBN, awarded to dogs successful in conformation shows) if available, and registration type, as well as identification of dog’s sire and dam. To identify dogs bred primarily for conformation shows, show breeding (SB) was calculated as twice the number of parents with SBN, plus the number of grand-parents with SBN, and so ranged between 0, where none of ancestors in last two generations had a SBN, and 8, where all ancestors had an SBN. The pedigree was checked and corrected for inconsistencies in parentage using custom Fortran 90 program. Inbreeding coefficients for all dogs in the pedigree were calculated using a Fortran 90 program following the algorithm of [51].

The coat colour was grouped into colours recognised in the breed standard for the breed (BS), and other colours labelled as non-breed standard (NBS). The list of coat colours and their assignment to the BS and NBS categories is shown in S1 Table.

To examine possible sample bias, statistics pertaining to show breeding and coat colours were compared between RFGS tested dogs and their contemporaries, selected from pedigree as RKC-registered dogs resident in the UK and born in the same period as tested dogs – with the cut-off date being the date of birth of the oldest tested dog in each breed. Similarly, percentage of RFGS tested dogs and percentages of litters born to tested parents were calculated based on the data for RKC-registered and UK-resident dogs.

Summary statistics

As the majority of the variables recorded were ordinal and showed substantial deviation from Gaussian assumptions, a range of statistical tests were used to ensure a robust inference. Between breed differences in RFGS grade, BCS, STEN grade, age in years, and the number of days between first and last record for dogs with multiple results, were assessed using Kruskal-Wallis rank sum test. Pairwise differences between breeds in RFGS grade and age in years were tested using Wilcoxon rank sum test, with Bonferroni correction for multiple testing. Wilcoxon rank sum test with continuity correction was used to assess if there was evidence of selection based on RFGS based on the difference in first available RFGS grade distribution between breeding dogs and dogs without registered offspring. To assess whether RFGS testing influenced sire selection, a two-sample t-test with unequal variances was used to compare the number of litters produced by tested versus untested sires. Between breeds sex distribution, BOAS prevalence, percentage of NBS dogs, count of dogs in show breeding categories and disease progression between first and last result were tested using Pearson Chi-squared test, followed by Chi-squared test with Bonferroni adjustment for multiple testing for pairwise breed differences. Within breed differences in mean body weight between males and females were assessed using t-test. Logistic regression models were used to assess odds of being tested given breed and show breeding, and to assess odds of being BOAS+ given coat colour group, obesity and STEN in each breed. Models were fitted with a binomial error distribution and logit link. Odds ratios (OR) with 95% confidence intervals (CI) were obtained by exponentiating regression coefficients. Where relevant, pairwise contrasts were estimated using marginal means with p-value adjustment for multiple testing.

Population structure

Population structure of each breed was examined through visual appraisal of the first two principal components (PC1 and PC2) calculated using randomised singular value decomposition in randPedPCA [52]. Scatter plots of PC1 and PC2 were generated with individuals coloured according to key factors relevant to this study -year of birth, coat colour group, show breeding and RFGS tested status. This allowed us to assess whether these variables corresponded to clustering patterns within each breed.

Animal models

Preliminary analyses involved heritability estimation using parent-offspring regression. Details of the method, models, and results are in S2 File. Final estimates were obtained from a mixed linear animal model incorporating all known pedigree relationships. Mixed linear univariate models were fitted to the RFGS data for each breed using ASRemlR [53] to assess the presence and magnitude of genetic variance in RFGS grades in Bulldog, French Bulldog and Pug, and to calculate estimated breeding values (EBVs). Separately, univariate mixed linear models were fitted to BW, BCS and STEN in each breed, and a log-likelihood ratio test as implemented in ASRemlR (LRT) was used to identify which of these traits had a significant genetic variance. A multivariate mixed linear model was fitted to RFGS grade and additional traits for which significant genetic variance was detected to calculate correlations between traits.

The univariate models fitted to the transformed RFGS grade, BW, BCS and the transformed STEN were:

y=Xβ+ Z1u1+ Z2u2+ Z3u3+f(x)+e (2)

where y is a vector of phenotypes, X is the design matrix for fixed effects and covariates described below: Z1, Z2 and Z3 are incidence matrices relating observations to the additive animal (u1), permanent environment (u2) and assessor (u3) effects, all assumed random, f(x) represents a smooth non-linear function of age, modelled using a natural cubic spline, and e is the vector of residuals. Random terms were assumed to be multi-variate normally distributed, with parameters u1~N(0,Aσa2), u2~N(0,Iσpe2), u3~N(0,Iσas2), and e~N(0,Iσe2), where A is the numerator relationship matrix, I is an identity matrix, and σa2, σpe2, σas2 and σe2 are variances corresponding to additive, permanent environment, assessor and residual terms respectively. The numerator relationship matrix was calculated from the pedigree restricted to tested dogs and their ancestors, using trimPed function from pedigree package [54]. Each of the random terms was tested using LRT, and with exception of splines, only terms significant for the trait in each breed were used in further analyses.

All models included sex fitted as a fixed effect, and a linear effect of age (in days) fitted as a covariate – in addition to the previously described random splines on age. Other terms: coat colour group, SB, year of birth and testing, ordinal date of test, coefficient of inbreeding (f) and protocol (for Bulldog and French Bulldog only), were tested through backwards elimination with Bayesian Information Criterion (BIC) used as a determinant. The tested terms were removed from the model if their removal resulted in BIC improvement of 2 or more [55]. In the analyses of additional research data, traits which did not have a significant genetic variance and obesity were added to the list of effects to be tested through backwards elimination.

Once the fixed effects and random terms were finalised for the univariate analysis of transformed RFGS grades, narrow sense heritability was calculated as proportion of the phenotypic variance explained by σa2. Phenotypic variance was calculated as a sum of σa2 and σe2, with addition of σpe2 in models where this component was significant. In those models, repeatability was also calculated, as a proportion of the phenotypic variance explained by the sum of σa2 and σpe2. The assessor term and spline on age were treated as a nuisance factor and were not included in the calculated phenotypic variance.

The final model was re-run using the entire pedigree to calculate EBVs for all individuals. Prediction error variances (PEV) were computed as the squared standard errors of EBVs, and the accuracies of the EBVs were calculated as:

=1−PEV(1+f)σa2 (3)

Where f is the inbreeding coefficient. Multivariate mixed models were fitted within breed to estimate the correlations between transformed RFGS grade and research data traits with significant genetic variance. Random terms were assumed to be normally distributed, with parameters u1~N(0,A⨂G), u2~N(0,I⨂C), and e~N(0,I⨂R), where G is the additive genetic (co)variance matrix across the traits, and C and R are assessor and residual (co)variance matrices respectively. No permanent environment covariances between traits were estimated. Fixed and random effects fitted to each trait were as stated for the univariate analyses. The significance of genetic and residual correlations between pairs of traits in each breed were tested using log-likelihood ratio test as implemented in ASRemlR [53].

Phenotypic correlations between traits i and j were calculated as:

rPij=σaij+σeij(σai2+σpei2+σei2)×(σaj2+σpej2+σej2) (4)

Where σaij and σeij were additive genetic and residual covariances, and σpei2 was a permanent environment variance fitted only in traits where it was deemed significant in univariate analyses. The estimates and standard errors of the phenotypic correlations were obtained using vpredict function in ASRemlR [53]. Phenotypic correlations between traits were tested for significance using the classical Fisher correlation test, implemented via the exact t-distribution for Pearson’s r, as

t=r(n−2)(1−r2), where r denotes the correlation estimate, and n is the number of observations where both traits i and j were recorded.

Results

Summary statistics for RFGS data

The prevalence of clinical BOAS was moderately low and differed significantly between breeds. French Bulldog had the lowest prevalence at 15.6%, compared with 18.9% in Bulldog (χ2=6.1, p_adj = 0.04) and 19.8% in Pug (χ2=7.1, p_adj = 0.02), with no significant difference between Bulldog and Pug (χ2=0.2, p_adj = 1). This corresponded to 26% (OR=1.26, CI: 1.05 to 1.51, p = 0.012) and 33% (OR=1.33, CI: 1.08 to 1.63, p = 0.012) higher odds of clinical disease in Bulldog and Pug respectively, compared with French Bulldog. RFGS grade distribution (Fig 1) also differed between breeds (χ2=79.2, p < 0.001), driven by French Bulldog, whose distribution differed significantly from both Bulldog and Pug (p_adj < 0.0001), while Bulldog and Pug did not differ (p_adj = 0.15). The summary statistics pertaining to the RFGS grades and dogs participating in the Scheme are presented in Table 1.

Fig 1. Distribution of RFGS grades between the breeds.

Fig 1

Table 1. Summary statistics for the RFGS data.

Bulldog French Bulldog Pug
Number of results 1,474 1,917 900
 Male 35.1% 38.4% 37.7%
 Female 64.9% 61.6% 62.3%
Age at testing in completed years – Median (Range, and IQR) 1.5 (1–10, IQR = 1) 1 (1–12, IQR = 1) 2 (1–12, IQR = 2)
Number of unique dogs 1,303 1,691 743
 Male 33.6% 38.0% 37.6%
 Female 66.4% 62.0% 62.4%
Coat colour; UKBreed (% of UKBreed tested)
 Breed Standard 81,354 (1.5%) 150,454 (0.8%) 105,757 (0.7%)
 Non-Breed Standard 39,433 (0.2%) 192,462 (0.3%) 11,523 (0.3%)
 Unknown 15 (6.7%) 87 (0.0%) 1 (0.0%)
Show Breeding; UKBreed (% of UKBreed tested)
 0 72,027 (0.3%) 324,720 (0.3%) 84,441 (0.2%)
 1 19,857 (0.9%) 8,298 (1.5%) 15,803 (0.4%)
 2 10,521 (1.8%) 4,643 (3.1%) 5,730 (1.4%)
 3 8,754 (2.4%) 2,648 (4.2%) 4,293 (1.8%)
 4 6,229 (3.9%) 1,491 (7.3%) 3,793 (2.8%)
 5 2,370 (5.7%) 523 (9.8%) 1,755 (4,7%)
 6 686 (9.6%) 422 (11.4%) 858 (7.9%)
 7 288 (10.1%) 194 (19.6%) 461 (14.5%)
 8 70 (10.0%) 64 (18.8%) 150 (19.3%)

IQR – Inter-quartile range; UKBreed - number of UK-resident dogs in particular category, born in the same period as tested dogs; % of UKBreed tested – indicates the percentage of UKBreed dogs which were RFGS tested.

There was a significant difference in distribution of age measured in years between breeds (χ2=86.9, p < 0.0001). Pug dogs were significantly older than both Bulldog and French Bulldog (p_adj < 0.0001), and the difference between the latter two breeds was less pronounced (p = 0.045). There was no significant difference in sex distribution (χ2=4.2, p = 0.123), with females over-represented in all three breeds.

Only a small percentage of dogs in each breed were tested under the RFGS. As shown in Fig 2A, the highest testing rate was found for Pug dogs born in 2023 (3.1%). Rates in French Bulldog and Bulldog remained low and stable since scheme inception in 2018, at 0.4–0.9%, and 1.3–1.7% respectively. In contrast, the percentage of litters sired by RFGS-tested dogs (Fig 2B) increased steadily, reaching 33.8% of Pug litters born in the first half of 2025, followed by 26.9% in Bulldog and 9.5% in French Bulldog. Litters with both parents tested remained rarer at 17.5%, 13.2% and 4.3% for Pug, Bulldog and French Bulldog respectively.

Fig 2. Percentages of the population tested using RFGS by year of birth.

Fig 2

A – percentage of UK-resident dogs RFGS tested. B – percentage of UK-born litters with either parent, or both parents RFGS tested.

There was modest evidence of phenotypic selection based on RFGS testing status and grade. In all three breeds, approximately half of the tested dogs were bred from (52.1%, 52.6% and 55.5% in Bulldog, French Bulldog and Pug respectively), and the number of litters produced by tested sires was significantly higher than that of untested sires (Table 2). In Bulldog and French Bulldog, breeding dogs had significantly lower mean first available RFGS grade than non-breeding dogs, although differences were small (Table 2). In Pug, there was no statistically significant difference in the distribution of RFGS grades between breeding and non-breeding dogs.

Table 2. Evidence of selection based on RFGS testing status and grade. 1) Mean number of litters per sire, with/out RFGS result, 2) Mean first available RFGS grade for dogs used in breeding and non-breeding dogs.

Bulldog French Bulldog Pug
1. Mean number of litters per sire Untested sire (SD) 4.99 (9.65) 4.82 (10.09) 5.18 (8.26)
Tested sire (SD) 8.88 (12.33) 7.94 (12.92) 7.40 (9.40)
p-value of difference <0.001 <0.001 0.007
2. Mean first available RFGS grade Breeding dogs (SD) 0.82 (0.71) 0.60 (0.66) 0.94 (0.70)
Non-breeding dogs (SD) 1.00 (0.82) 0.89 (0.86) 1.03 (0.79)
p-value of difference <0.001 <0.001 Not significant

Across the RFGS data, the majority (n = 3274) of the dogs were tested only once. However, nearly a quarter (23.6%) of the RFGS grades were recorded on dogs with multiple records, including 192 males contributing 423 records, and 271 females contributing 589 records. Most (n = 385) dogs in this group were tested twice. The highest number of results recorded on a single dog was 7, with all results showing the same RFGS grade. Comparing the first and last available record, RFGS grades remained the same for the majority of the dogs (n = 274), followed by 101 dogs for which last grade was better than first, and 88 dogs for which grade worsened over time. The progression of RFGS grades differed significantly between breeds (p < 0.001), however, so did the number of days between first and last test (p < 0.001), as shown in Table 3.

Table 3. Number of dogs whose last RFGS grade improved, remained the same or worsened as compared to the first available grade, across the three breeds.

Breed Improved Same Worsened Mean days between tests (±SD)
Bulldog 36 92 27 697.18 (441.47)
French Bulldog 24 123 31 793.75 (425.73)
Pug 41 59 30 933.40 (531.73)

Summary statistics for the research data

The summary statistics for BW, BCS and STEN are shown in Table 4. Distribution of BW was approximately normal in all three breeds, as shown in Fig 3A, and in all three breeds males were significantly heavier than females (p < 0.0001). The distribution of BCS (Fig 3B) and STEN differed significantly between breeds (p < 0.0001). Pug had the highest percentage of obese dogs at 16.8%, and French Bulldog had the lowest percentage of dogs with open nostrils at 6.2%.

Table 4. Summary statistics for additional research data.

Bulldog French Bulldog Pug
Weight (kg) (n) 769 1,046 433
 Mean (±SD) 24.3 (3.61) 12.0 (2.13) 8.4 (1.39)
 Mean (±SD) Dog 26.8 (3.38) 13.1 (2.04) 9.3 (1.35)
 Mean (±SD) Bitch 23.0 (2.96) 11.3 (1.87) 7.9 (1.16)
BCS (1–9) (n) 1,061 1,487 536
 Median (Range, IQR) 5 (2–8, IQR = 1) 5 (2–8, IQR = 0) 6 (4–9, IQR = 1)
 Obese 8.5% 2.6% 16.8%
Nostril Stenosis 1,077 1,507 549
 Open 23.3% 6.2% 14.8%
 Mild 54.7% 42.6% 45.0%
 Moderate 20.7% 45.2% 38.1%
 Severe 1.3% 6.0% 2.2%

Fig 3. Distribution of body weight (A) and body condition score (B) across the three breeds.

Fig 3

Across all three breeds, obese dogs had 3.8x (CI: 2.87–5.09, p < 0.0001) higher odds of being clinically affected by BOAS, with the within breed odds of 3.7x (CI: 2.39–5.82), 2.9x (CI: 1.46–5.76) and 4.5x (CI: 2.75–7.44) for Bulldog, French Bulldog and Pug respectively. Similarly, dogs with stenotic nares had 2.6x (CI: 2.16–3.13, p < 0.0001) higher odds of being clinically affected by BOAS, with the within breed odds of 2.7x (CI: 1.93–3.69), 4.0x (CI: 2.91–5.57) and 2.7x (CI: 1.75–4.16) for Bulldog, French Bulldog and Pug respectively.

Population structure

The contemporary populations of all three breeds were dominated by dogs with no ancestors winning conformation shows (SB = 0), although the distribution of SB categories differed substantially between breeds (χ2=91,644, p < 0.0001). The highest percentage of dogs with SB = 0 was observed in French Bulldog (94.7%), followed by Pug (72.0%) and Bulldog (59.6%).

Dogs of non-breed standard colours (NBS) were common within the contemporaries of RFGS-tested dogs, but their percentage varied markedly between breeds (χ2=82,317, p_adj < 0.0001). The percentages of NBS dogs ranged from 9.8% in Pug, through 32.6% in Bulldog and 56.1% in French Bulldog.

Population structure analyses indicated emerging genetic divergence between coat colour groups within each breed. PCA plots (Fig 4) showed that, within each breed, dogs born since 2016 formed a single contemporary cluster; however, BS and NBS dogs were positioned toward opposite extremes of their respective breed clusters. PCA plots stratified by year of birth (S1–S3 Figs) showed that the separation between coat colour groups became more apparent in recent cohorts, coinciding with the expansion in popularity of these breeds. While some temporal dispersion over time is expected due to pedigree including dogs with unknown parentage treated as founders [52], the consistent positioning of coat colour groups toward opposite extremes suggests emerging population substructure. RFGS testing patterns overlapped strongly with show breeding in all breeds.

Fig 4. Principal component analysis (PCA) plot of population structure in Bulldog (A – C), French Bulldog (D – F) and Pug (G – I).

Fig 4

First column illustrates population structure in context of coat colour, second column in context of show breeding and third column in context of RFGS testing status. Dogs marked in grey were defined as historic dogs born before 2016.

RFGS participation was strongly associated with show-breeding background, with each step increase in SB raising the odds of being tested by 71% (CI: 66.7 to 75.6) in Bulldog, 97.4% (CI: 92.7 to 102.1) in French Bulldog and 85.0% (CI: 80.0 to 90.0%) in Pug.

RFGS participation was also strongly associated with BS coat colour. In all three breeds, dogs of BS colour were more commonly tested than NBS dogs, with odds ratio of 9.2x (CI: 7.2 to 11.8, p_adj < 0.001) in Bulldog, 3.0x (CI: 2.7 to 3.3, p_adj < 0.0001) in French Bulldog and 2.3x (CI: 1.6 to 3.2, p_adj < 0.001) in Pug. Although the sample sizes of NBS dogs were generally small, the odds of being BOAS+ were higher for NBS dogs, at 2.9x (CI: 1.72 to 4.70) in Bulldog, 1.9x (CI: 1.45 to 2.42) in French Bulldog and 3.6x (CI: 1.81 to 7.23) in Pug.

Genetic parameters of RFGS grade

All three breeds showed significant genetic variance in RFGS grade, with moderate heritability estimates and high repeatability where estimable. Heritability ranged from 0.21 (SE 0.06) in Bulldog to 0.45 (SE 0.06) in French Bulldog, with Pug at 0.28 (0.07). Repeatability was high in Bulldog (0.49, SE 0.07) and French Bulldog (0.61, SE 0.05), while in Pug the permanent environment effect was not significant and thus no repeatability estimate was calculated. Fixed effects structures were the same for Bulldog and Pug (Table 5). Age had a significant but small linear effect only in Pug (0.13 ± 0.03 units per SD increase in age, equivalent to 0.07 per year). Sex was significant in Bulldog and French Bulldog, with females showing lower RFGS grades, whereas in Pug the sex difference was nonsignificant but slightly higher in females. Non-linear age splines were not significant in any breed but were retained for consistency.

Table 5. Fixed effects used in the final models used to derive estimates of RFGS grade heritability in the three breeds. P-values <0.05 marked in bold.

Bulldog French Bulldog Pug
Effect Estimate (SE) p-valuea Estimate (SE) p-valuea Estimate (SE) p-valuea
Intercept 0.21 (0.12) 0.340 0.31 (0.08) 0.193 0.08 (0.10) 0.086
Sex (male as reference) −0.30 (0.05) <0.001 −0.33 (0.04) <0.001 0.08 (0.06) 0.194
Age in days (scaled and centred) 0.02 (0.03) 0.441 0.05 (0.03) 0.128 0.13 (0.03) <0.001
Colour group (BS as reference) 0.26 (0.15) 0.095 0.35 (0.17) 0.038
f −0.52 (0.55) 0.346 0.14 (0.59) 0.817 −0.54 (0.69) 0.430
Year of birth (centred) 0.13 (0.07) 0.071
Ordinal date of birth (scaled and centred) −0.23 (0.15) 0.113

Intercept represents the expected response for a male of a breed standard colour, with coefficient of inbreeding (f) of 0, of mean age, mean year and date of birth.

a P-values were calculated using the Wald test.

EBV accuracy for RFGS grade was generally low across breeds. Distribution of the accuracies for dogs born since 2016 is shown on Fig 5, with median accuracies of 0.24, 0.26 and 0.22 for Bulldog, French Bulldog and Pug. Only a small percentage of contemporary dogs exceeded the accuracy expected from selection on phenotype alone. The dissemination of information from phenotyped dogs through the pedigree differed across breeds: Bulldog showed the widest spread of information, whereas in French Bulldog the percentage of dogs with highly accurate EBVs mirrored the percentage of phenotyped dogs, indicating poor propagation of phenotypic information. Accuracies differed between BS and NBS dogs in Bulldog and Pug, with higher median accuracies in BS dogs; this contrast was most pronounced in Bulldog (0.33 vs 0.19), compared to a smaller difference in Pug (0.22 vs 0.19). No difference in median EBV accuracy between colour groups was observed in French Bulldog.

Fig 5. Distribution of EBV accuracies in Bulldog (A), French Bulldog (B) and Pug (C) born since 2016.

Fig 5

First column shows the distribution of accuracies across all individuals, with vertical lines indicating accuracies expected given selection based on individual’s own phenotype (h2, marked in blue), and accuracy expected given parental average only (0.5h2, marked in red); with percentages indicating population exceeding given accuracy threshold. Second column illustrates the distribution of EBV accuracies split between BS and NBS dogs.

Correlations between RFGS grade and conformation traits

Multivariate models identified significant genetic variance in STEN grade and BW across all three breeds, and in BCS in French Bulldog, with notable genetic correlations between traits. The strongest significant genetic correlation was observed between STEN and RFGS grades in French Bulldog (Table 6). Assessor effects were positively correlated for RFGS and STEN grades in both Bulldog (0.66, SE 0.19, p = 0.007) and Pug (0.68, SE 0.20, p = 0.015), and in Pug the assessor effect was also shared between BW and STEN grade (0.60, SE 0.23, p = 0.033). Residual correlations were positive and significant for most trait pairs in French Bulldog and Bulldog, except correlation between BW and STEN grade (non-significant in both breeds) and RFGS grade and BW, which reached significance only at p < 0.1 in French Bulldog. Full results for residual and assessor correlations are presented in S2 Table.

Table 6. Results of multi-variate analyses.

Bulldog French Bulldog Pug
RFGS grade BW STEN grade RFGS grade BW STEN grade BCS RFGS grade BW STEN grade
RFGS grade 0.17 (0.07) −0.42 (0.17)
**
0.41 (0.20)* 0.43 (0.06) −0.09 (0.08) 0.59 (0.08)*** −0.31 (0.14)* 0.39 (0.09) 0.14 (0.15) 0.09 (0.21)
BW −0.06 (0.04) 0.60 (0.07) −0.09 (0.14) 0.00 (0.03) 0.73 (0.04) −0.21 (0.09)* 0.16 (0.11) 0.02 (0.07) 0.52 (0.12) 0.03 (0.17)
STEN grade 0.20 (0.03)
***
−0.04 (0.04) 0.31 (0.07) 0.36 (0.03)*** −0.08 (0.03)** 0.39 (0.07) −0.23 (0.14) 0.13 (0.05)*** −0.02 (0.05) 0.32 (0.09)
BCS 0.06 (0.03)** 0.29 (0.03)*** 0.02 (0.03) 0.25 (0.05)

Diagonal cells marked in grey show heritability; cells above the diagonal show genetic correlations; cells below show phenotypic correlations. All models included sex, linear age, age splines, and coefficient of inbreeding. Colour group was fitted in Bulldog and Pug only. BCS was included as a covariate for grade and BW in Bulldog and Pug, and as a separate trait in French Bulldog. Obesity was fitted for all traits except grade in Pug. Year of test and date of birth were fitted to BW and STEN grade in Bulldog and French Bulldog, and date of birth was also fitted to STEN grade in Pug. Protocol was fitted only for STEN grade in Bulldog, and year of birth only for BW in Bulldog.

Significance is indicated by p < 0.05 (*), p < 0.01 (**), p < 0.001 (***).

Discussion

This study provides the most comprehensive genetic analysis of BOAS-related traits in UK RKC registered populations of the three principal brachycephalic breeds to date. We report prevalence estimates of clinically expressed BOAS that differ from what has been previously documented and demonstrate that within-breed selection has the potential to achieve meaningful genetic improvement. Moderate heritability estimates for RFGS grade, together with additional estimates for stenotic nares and body weight, expand our current understanding of the genetic architecture underlying BOAS and its associated conformational traits. The study also offers practical recommendations for the continued development of the RFGS scheme and provides demographic insights showing population substructure. Further, our data indicate that a large percentage of dogs bred in the UK do not conform to their breed standards, and that participation in health testing, although still limited, is higher among dogs linked to conformation-show lines.

The estimated prevalence of BOAS in our study (16–20%) is substantially lower than previously reported [11,16,17,22,38,40,47]. Because participation in RFGS testing is voluntary, the true prevalence is likely higher, as the most severely affected dogs may be under-represented in RFGS data. Nevertheless, our estimates derive from the largest datasets currently available for the UK Bulldog, French Bulldog and Pug populations.

Earlier reference values for BOAS prevalence (51% − 64%) were based on cohorts of approximately 200 dogs per breed [17]. In contrast, our study utilised samples that were 5–10 times larger and with notable differences in composition. For example, we observed substantially fewer obese dogs, with the highest percentage in Pug at 17% compared to 61% reported by [17], despite similar median BCS across the two studies. This may indicate that educational activities associated with RFGS testing have influenced management practices related to body condition within participating breed communities, potentially contributing to the lower observed prevalence of BOAS. Our data may also reflect an early response to phenotypic selection, as suggested by lower RFGS grades among breeding dogs in Bulldogs and French Bulldogs.

Historically, RFGS breeding guidelines recommended by the RKC [56] permitted the use of grade 2 dogs for breeding, partly to avoid excessive restriction of the gene pool given high reported BOAS prevalence. However, with the present study indicating that over 75% of tested dogs in each breed are classified as BOAS-, there is scope to further revise these recommendations. Excluding grade 2 dogs from breeding entirely would increase the selection differential, and consequently, could accelerate genetic improvement in respiratory health.

The presence of significant additive genetic variation in the RFGS grades across all three breeds indicates that within-breed selection is feasible. This study provides the first pedigree-based, within-breed heritability estimates for BOAS. Our estimates are broadly comparable to the across-breed estimate of 0.4 (SE 0.16) reported in Finnish brachycephalic breeds based on parent-offspring regression [47]. However, the Finnish populations are smaller and characterised by substantially higher testing uptake. In the present dataset, under-representation of severely affected dogs could restrict phenotypic variance and result in conservative estimates of additive genetic variance. Given differences in population structure, participation rates, methodology, and the relatively large standard error of the Finnish estimate, direct comparison between studies should therefore be interpreted with caution.

The mixed linear model applied here enables more comprehensive partitioning of phenotypic variance than parent-offspring regression by incorporating additional variance components, e.g., permanent environment effect. Both pedigree-based approaches may be influenced by pedigree errors. Genomic methods, which estimate realised genetic sharing, avoid this limitation and improve the response to selection when combined with large-scale phenotyping. To date, BOAS heritability has been estimated using genomic data only once, in a UK sample of approximately 200 dogs per breed [48], yielding an estimate of 0.6. In general, SNP array-based estimates are expected to be lower than pedigree-based estimates because they capture only the proportion of the additive variance tagged by genotyped markers [57]. The lower estimates observed in the present study may reflect the conservative bias related to sampling structure, however, limited methodological detail from [48] prevents firm conclusions regarding the discrepancy.

Significant genetic variance implies that EBV-based selection could be implemented to support more accurate identification of genetic predisposition by incorporating extended pedigree information, and controlling for environmental effects such as the highly significant assessor effect observed here and elsewhere [58].We found that in Bulldog and Pug, the number of dogs with highly accurate EBVs already exceeded the number of phenotyped dogs, illustrating effective dissemination of information from phenotyped dogs through related individuals.

The greatest limitation to both phenotype-based and EBV-based selection remains the low participation in RFGS. Although the percentage of litters from tested parent/s is increasing, the overall engagement remains limited. Danish data indicate promising interest among puppy buyers in purchasing puppies from tested parents [25], however, the same owners remain reluctant to test their own dogs. In the UK, where breed communities have shown limited interest in outcrossing and rely heavily on the within-breed selection approach, increasing participation will be essential for achieving population-wide improvement.

In Denmark, all breeding dogs in Bulldog, French Bulldog and Pug, regardless of pedigree, are legally required to undergo RFGS assessment, with only grades 0 and 1 permitted for breeding [25]. Mandatory health testing can be a powerful tool when supported through national legislation. However, when introduced solely by kennel clubs, such measures risk reducing registration rates rather than increasing participation in health schemes if owners move to unregistered breeding. In the UK, only an estimated 29% of dogs are registered with the RKC [59], and the popularity of RKC-registered dogs has declined in recent years [60]. Maintaining strong connections with the RKC is important, because the RKC-registered communities remain the most directly accessible to health-improvement campaigns.

Our demographic analyses show that the awareness and popularity of health testing is substantially higher among communities involved in conformation showing, demonstrating that those most closely linked to the RKC are also the groups most consistently exposed to, and engaged with, educational efforts. Nevertheless, even among dogs with all recent ancestors successful in conformation shows, only between 10–20% have been RFGS tested. Participation is expected to increase as the RKC implements new requirements: from 2025, all dogs in Bulldog, French Bulldog and Pug entered at Crufts – the RKC’s flagship event and one of the largest dog shows in the world – must undergo RFGS testing, with grade 3 dogs excluded from the competition. From 2026, dogs graded 2 or 3 will no longer be eligible to attend [61].

Conversely, dogs distant from conformation showing and those not fitting breed standard by their coat colour, are under-represented in the tested population, and show slightly worse RFGS grades. There is no evidence that any of the NBS colours are genetically correlated to BOAS, and this is unlikely given the same colour genotype can be considered BS in one breed and NBS in another. For example, black coat colour, determined by CBD103 and TYRP1 [62,63] and common across various dog breeds, is a standard colour in the Pug but non-standard in Bulldogs. Poorer RFGS grades among NBS dogs therefore likely reflect sampling bias, or alternatively, lower levels of health-based selection within NBS breeding communities. Our current sample sizes for NBS dogs are limited, preventing firm conclusions.

Our demographic findings provide additional insight into the proposed strategy of addressing the “brachycephalic crisis” through revisions to breed standards. While breed standards have historically guided conformation goals, adherence is formally assessed only within the conformation show ring. Participation in conformation showing and the use of show dogs in breeding have declined markedly in recent years [60]. Our data shows, for the first time, that the surge in popularity of extreme brachycephalic breeds has been driven largely by dogs that deviate from breed standards at the most obviously visible level of coat colour.

Data from RFGS further indicate the limited influence of breed standard wording on the current UK population. For example, the French Bulldog standard explicitly calls for “well-opened nostrils” [64], a requirement that has remained unchanged in the UK standard since the early 1990’s (A. Skipper, personal communication). And yet, our data demonstrate that nostril stenosis remains widespread with only 6% of tested French Bulldog graded as having open nostrils. Thus, while it remains essential that breed standards avoid endorsing exaggerated conformation, changes to wording alone are unlikely to meaningfully influence the wider population, which is already dominated by dogs outside the standard.

The primary efforts should focus on increasing preference for functional traits. As we demonstrate here, selection of breeding stock based on functional traits is feasible. We present, for the first time, estimates of the heritability of nostril stenosis in three brachycephalic breeds, and quantify their genetic correlation with RFGS grade. Although stenotic nares are widely documented as one of the primary conformational contributors to BOAS [17,33,65]), the genetic relationship between those two traits is complex. Notably, in our data the breed with the highest prevalence of stenotic nostrils (French Bulldog) also showed the lowest prevalence of BOAS. Our analyses show that RFGS grade and stenosis are positively genetically correlated, with moderately high estimates, but represent genetically distinct traits. This suggests that selection strategies targeting both traits simultaneously could be more effective than relying on either trait alone.

We also provide the first heritability estimates for body weight in the three extreme brachycephalic breeds. Although body weight is known to be highly heritable in humans, estimates for dogs remain scarce and have not previously included these breeds [66,67]. Our moderately high estimates fall near the upper range of those reported for non-brachycephalic breeds in Sweden [65], and are substantially higher than the heritability of 0.18 reported for adult weight in Boxers [66]. As the body weight observations in our study were corrected for obesity, and for BCS in Bulldog and Pug, these estimates likely represent the genetic determinism of body size rather than fat deposition.

Although BCS is often considered a primarily management-related trait influenced by factors such as diet [68], exercise [69], or neutering [70], genetic contributions to this trait have been reported. In Labrador Retrievers, BCS showed a heritability of 0.7 and an association with the DENND1B gene [71], though this effect appears breed-specific. In our dataset, additive genetic variance for BCS was detected only in French Bulldog, despite clear phenotypic variation in all three breeds. This may reflect limited sample size, particularly for Pug, or potentially a lower genetic determinism of BCS in these breeds.

Obesity and high BCSs are frequently cited as risk factors for BOAS [9,10,16]. Using a multivariate animal model, we explored the genetic relationships between body size measures and RFGS grade, and detected several statistically significant genetic correlations. Counterintuitively, the significant estimates between RFGS grade and BW in Bulldog, and between RFGS grade and BCS in French Bulldog, were negative. Because both BW and BCS had been corrected for obesity, these results suggest that larger, but not obese, dogs may be less genetically predisposed to BOAS. However, it is important to note that dogs severely affected with BOAS often experience regurgitation [14], which can reduce BCS and potentially bias phenotypic observations. In a previous analysis of French Bulldog, nearly 10% of RFGS grade 3 dogs were scored as underweight, which was attributed to regurgitation [17] (Liu et al., 2017). Additional data, especially in Pug where none of the genetic correlations reached statistical significance, are needed to clarify the pleiotropic relationships between body size and respiratory function. Taken together with the significant genetic correlations among body weight, BCS, RFGS grade and nostril stenosis, our findings suggest that selection against BOAS could be more effective when all four traits are recorded and evaluated jointly within a multivariate framework.

Our findings have further implications for the organisation of the RFGS scheme. Although age at testing had a significant effect on the RFGS grade in our data, the magnitude of this effect was extremely small, consistent with previous studies showing minimal or no influence of age [10,11,15,16]. Combined with high repeatability estimate for Bulldog and French Bulldog, these results raise questions about the necessity of repeated measurements throughout a dog’s life. While veterinary care for BOAS is typically sought between 3 (Monnet, 2011) and 6 [72] years of age, this reflects owner decision-making rather than appearance of clinical signs detectable by trained RFGS assessors.

Although our findings substantially advance the understanding of BOAS and provide refined guidance for developing effective selection strategies, several limitations should be considered. First, the data used here were obtained through voluntary participation, which may introduce sampling bias and limit the representativeness of the wider UK population. Second, while BOAS remains the most recognised and extensively studied component of the brachycephalic syndrome, it does not encompass its full clinical spectrum [73]. Other conditions, including ocular disease [74], middle ear effusions [75] or gastrointestinal abnormalities [76] also contribute to the overall welfare burden. Some, particularly sleep and gastrointestinal issues, may improve alongside better respiratory function, but comprehensive evaluation of the entire brachycephalic syndrome was beyond the scope of this study.

Conclusions

This study analysed the largest RFGS dataset to date and shows that BOAS prevalence in RKC registered UK Bulldogs, French Bulldogs and Pugs is lower than previously reported, supporting refinement of current RFGS breeding recommendations. We identified substantial genetic variance in RFGS grade, stenotic nares and body weight, as well as meaningful genetic correlations among these traits, demonstrating that within-breed selection may improve respiratory health, particularly when multiple BOAS-related traits are recorded and evaluated together. However, the impact of any selection programme will depend on the levels of participation. Engagement with RFGS testing remains low, especially outside show-associated subpopulations, and increasing uptake is essential to achieve population-wide improvements in respiratory function.

Supporting information

S1 File. Details of the respiratory function grading scheme.

(DOCX)

pone.0348023.s001.docx (18.4KB, docx)
S2 File. Preliminary estimation of heritability of RFGS Grade using parent offspring regression.

(DOCX)

pone.0348023.s002.docx (15.1KB, docx)
S1 Fig. PCA plot of Bulldog population, stratified by year of birth and coat colour group.

(GIF)

pone.0348023.s003.gif (925.8KB, gif)
S2 Fig. PCA plot of French Bulldog population, stratified by year of birth and coat colour group.

(GIF)

pone.0348023.s004.gif (769.5KB, gif)
S3 Fig. PCA plot of Pug population, stratified by year of birth and coat colour group.

(GIF)

S1 Table. Coat colours in the three breeds divided into breed standard, and non-breed standard.

(XLSX)

pone.0348023.s006.xlsx (24.7KB, xlsx)
S2 Table. Residual and assessor effect correlation between traits used in multivariate analyses.

(DOCX)

pone.0348023.s007.docx (15.9KB, docx)
S3 Table. Pedigree for Bulldog.

(CSV)

pone.0348023.s008.csv (17.5MB, csv)
S4 Table. Pedigree for French Bulldog.

(CSV)

pone.0348023.s009.csv (33.6MB, csv)
S5 Table. Pedigree for Pug.

(CSV)

pone.0348023.s010.csv (13.4MB, csv)
S6 Table. Phenotypes for Bulldog.

(CSV)

pone.0348023.s011.csv (127.3KB, csv)
S7 Table. Phenotypes for French Bulldog.

(CSV)

pone.0348023.s012.csv (167.4KB, csv)
S8 Table. Phenotypes for Pug.

(CSV)

pone.0348023.s013.csv (75.8KB, csv)

Acknowledgments

The authors would like to thank colleagues at the RKC for their ongoing support, as well as day to day management of the RFGS. We are also very grateful to Nai-Chieh Liu DVM MPhil PhD and Fran Tomlinson MA VetMB MRCVS for their dedication and expertise in the development of the RFGS. Finally, we thank the breeders and owners who presented their dogs for testing. Their participation is essential in generating the data needed to improve opportunities for selection against the disease and, ultimately, to support better health outcomes in their breeds.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Asher L, Diesel G, Summers JF, McGreevy PD, Collins LM. Inherited defects in pedigree dogs. Part 1: Disorders related to breed standards. Vet J. 2009;182(3):402–11. doi: 10.1016/j.tvjl.2009.08.033 [DOI] [PubMed] [Google Scholar]
  • 2.Bateson P. Independent inquiry into dog breeding. Univ Camb; 2010. pp. 32–3. [Google Scholar]
  • 3.Bonnett BN. Brachycephalics: ‘Once a problem is seen it cannot be unseen’. Canine Med Genet. 2023;10(1):3. doi: 10.1186/s40575-023-00126-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Farrow T, Keown A, Farnworth M. An exploration of attitudes towards pedigree dogs and their disorders as expressed by a sample of companion animal veterinarians in New Zealand. N Z Vet J. 2014;62(5):267–73. doi: 10.1080/00480169.2014.902340 [DOI] [PubMed] [Google Scholar]
  • 5.Menor-Campos DJ. Ethical concerns about fashionable dog breeding. Animals. 2024;14(5):1–25. doi: 10.3390/ani14050756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Proschowsky HF, Arendt ML, Bonnett BN, Bruun CS, Czycholl I, Fredholm M, et al. A new future for dog breeding. Anim Welf. 2025;34. doi: 10.1017/awf.2024.66 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rooney NJ, Sargan DR. Welfare concerns associated with pedigree dog breeding in the UK. Anim Welf. 2010;19(SUPPL. 1):133–40. [Google Scholar]
  • 8.Ekenstedt KJ, Crosse KR, Risselada M. Canine brachycephaly: anatomy, pathology, genetics and welfare. J Comp Pathol. 2020;176:109–15. doi: 10.1016/j.jcpa.2020.02.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Packer RMA, Hendricks A, Tivers MS, Burn CC. Impact of facial conformation on canine health: brachycephalic obstructive airway syndrome. PLoS ONE. 2015;10(10):e0137496. doi: 10.1371/journal.pone.0137496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ravn-Mølby EM, Sindahl L, Nielsen SS, Bruun CS, Sandøe P, Fredholm M. Breeding French bulldogs so that they breathe well—A long way to go. Loor JJ, editor. PLOS ONE. 2019;14(12):e0226280. doi: 10.1371/journal.pone.0226280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Liu N-C, Sargan DR, Adams VJ, Ladlow JF. Characterisation of brachycephalic obstructive airway syndrome in French Bulldogs using whole-body barometric plethysmography. PLoS ONE. 2015;10(6):e0130741. doi: 10.1371/journal.pone.0130741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ladlow JF. Brachycephalic obstructive airway syndrome: guide to the respiratory functional grading scheme. In Pract. 2021;43(10):548–55. [Google Scholar]
  • 13.Monnet E. Brachycephalic airway syndrome. Orlando, Florida, USA: CABI; 2011. pp. 1431–3. [Google Scholar]
  • 14.Roedler FS, Pohl S, Oechtering GU. How does severe brachycephaly affect dog’s lives? Results of a structured preoperative owner questionnaire. Vet J. 2013;198(3):606–10. doi: 10.1016/j.tvjl.2013.09.009 [DOI] [PubMed] [Google Scholar]
  • 15.Aromaa M, Rajamäki M, Lilja-Maula L. A follow-up study of exercise test results and severity of brachycephalic obstructive airway syndrome signs in brachycephalic dogs. Anim Welf. 2021;30(4):441–8. doi: 10.7120/09627286.30.4.007 [DOI] [Google Scholar]
  • 16.Liu N, Adams VJ, Kalmar L, Ladlow JF, Sargan DR. Whole‐body barometric plethysmography characterizes upper airway obstruction in 3 brachycephalic breeds of dogs. J Vet Intern Med. 2016;30(3):853–65. doi: 10.1111/jvim.13933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Liu N-C, Troconis EL, Kalmar L, Price DJ, Wright HE, Adams VJ, et al. Conformational risk factors of brachycephalic obstructive airway syndrome (BOAS) in pugs, French bulldogs, and bulldogs. PLoS ONE. 2017;12(8):e0181928. doi: 10.1371/journal.pone.0181928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Skipper A. A historical perspective on brachycephalic breed health and the role of the veterinary profession. In: Packer R, O’Neill D, editors. Health and welfare of brachycephalic (flat-faced) companion animals: a complete guide for veterinary and animal professionals. 1st ed. Boca Raton, FL: CRC Press; 2021. pp. 7–24. [Google Scholar]
  • 19.Farquharson FJ, Smith KW. Resection of the soft palate in the dog. J Am Vet Med Assoc. 1942;100. [Google Scholar]
  • 20.O’Neill DG, Jackson C, Guy JH, Church DB, McGreevy PD, Thomson PC, et al. Epidemiological associations between brachycephaly and upper respiratory tract disorders in dogs attending veterinary practices in England. Canine Genet Epidemiol. 2015;2(1). doi: 10.1186/s40575-015-0023-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.O’Neill DG, Skipper AM, Kadhim J, Church DB, Brodbelt DC, Packer RMA. Disorders of Bulldogs under primary veterinary care in the UK in 2013. PLoS ONE. 2019;14(6):e0217928. doi: 10.1371/journal.pone.0217928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Njikam Nsangou I, Huault M, Pirson V, Detilleux J. The influence of phylogenic origin on the occurrence of brachycephalic airway obstruction syndrome in a large retrospective study. Int J Appl Res Vet Med. 2009;7(3). [Google Scholar]
  • 23.Åsbjer E, Hedhammar Å, Engdahl K. Awareness, experiences, and opinions by owners, breeders, show judges, and veterinarians on canine Brachycephalic Obstructive Airway Syndrome (BOAS). Canine Med Genet. 2024;11(1):3. doi: 10.1186/s40575-024-00137-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Packer R, Hendricks A, Burn C. Do dog owners perceive the clinical signs related to conformational inherited disorders as ‘normal’ for the breed? A potential constraint to improving canine welfare. Anim Welf. 2012;21(S1):81–93. doi: 10.7120/096272812x13345905673809 [DOI] [Google Scholar]
  • 25.Proschowsky HF, Springer S, Lotze S, Rafn F, Sandahl Z, Bruun CS. Perception of dog health and attitudes towards BOAS grading among Danish owners of French bulldog. Front Vet Sci. 2025;12:1605505. doi: 10.3389/fvets.2025.1605505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sandøe P, Kondrup SV, Bennett PC, Forkman B, Meyer I, Proschowsky HF, et al. Why do people buy dogs with potential welfare problems related to extreme conformation and inherited disease? A representative study of Danish owners of four small dog breeds. PLoS ONE. 2017;12(2):e0172091. doi: 10.1371/journal.pone.0172091 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.O’Neill DG, McMillan KM, Church DB, Brodbelt DC. Dog breeds and conformations in the UK in 2019: VetCompass canine demography and some consequent welfare implications. PLoS ONE. 2023;18(7):e0288081. doi: 10.1371/journal.pone.0288081 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cannas S, Palestrini C, Boero S, Garegnani A, Mazzola SM, Prato-Previde E, et al. Italians can resist everything, except Flat-Faced Dogs! Animals. 2025;15(10):1496. doi: 10.3390/ani15101496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Packer R, Murphy D, Farnworth M. Purchasing popular purebreds: investigating the influence of breed-type on the pre-purchase motivations and behaviour of dog owners. Anim Welf. 2017;26(2):191–201. doi: 10.7120/09627286.26.2.191 [DOI] [Google Scholar]
  • 30.Packer RMA, Wade A, Neufuss J. Nothing could put me off: assessing the prevalence and risk factors for perceptual barriers to improving the welfare of brachycephalic dogs. Pets. 2024;1(3):458–84. doi: 10.3390/pets1030032 [DOI] [Google Scholar]
  • 31.Pound L, Farrow M, O’Neill D, Deane DJ, Packer RMA. All I do is fight fires: qualitative exploration of UK veterinarians’ attitudes towards and experiences of pre‐purchase consultations regarding brachycephalic dogs. Vet Rec. 2024;194(7):e3897. doi: 10.1002/vetr.3897 [DOI] [PubMed] [Google Scholar]
  • 32.O’Neill DG, Skipper A, Packer RMA, Lacey C, Brodbelt DC, Church DB, et al. English Bulldogs in the UK: a VetCompass study of their disorder predispositions and protections. Canine Med Genet. 2022;9(1). doi: 10.1186/s40575-022-00118-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Packer RM, Tivers M. Strategies for the management and prevention of conformation-related respiratory disorders in brachycephalic dogs. Vet Med Res Rep. 2015;:219. doi: 10.2147/vmrr.s60475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Packer RMA, O’Neill DG. Health and welfare of brachycephalic (flat-faced) companion animals: a complete guide for veterinary and animal professionals. 1st ed. Boca Raton: CRC Press; 2022. [Google Scholar]
  • 35.Youens E, O’Neill DG, Belshaw Z, Mochizuki S, Neufuss J, Tivers MS. Beauty versus the beast: The UK public prefers less‐extreme body shapes in brachycephalic dog breeds. Vet Rec. 2025. doi: 10.1002/vetr.5671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Packer RMA, O’Neill DG, Fletcher F, Farnworth MJ. Come for the looks, stay for the personality? A mixed methods investigation of reacquisition and owner recommendation of Bulldogs, French Bulldogs and Pugs. PLoS ONE. 2020;15(8):e0237276. doi: 10.1371/journal.pone.0237276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Steinert K, Kuhne F, Kramer M, Hackbarth H. People’s perception of brachycephalic breeds and breed-related welfare problems in Germany. J Vet Behav. 2019;33:96–102. doi: 10.1016/j.jveb.2019.06.006 [DOI] [Google Scholar]
  • 38.Aromaa M, Lilja-Maula L, Rajamäki M. Assessment of welfare and brachycephalic obstructive airway syndrome signs in young, breeding age French Bulldogs and Pugs, using owner questionnaire, physical examination and walk tests. Anim Welf. 2019;28(3):287–98. doi: 10.7120/09627286.28.3.287 [DOI] [Google Scholar]
  • 39.Schmid C, Steiner AR, Spielhofer L, Galfetti M, Rentsch N, Bogdanov N. Anatomical, functional, and blood-born predictors of severity of brachycephalic obstructive airway syndrome severity in French Bulldogs. Front Vet Sci. 2025;11. doi: 10.3389/fvets.2024.1486440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bartels A, Martin V, Bidoli E, Steigmeier-Raith S, Brühschwein A, Reese S, et al. Brachycephalic problems of pugs relevant to animal welfare. Anim Welf. 2015;24(3):327–33. doi: 10.7120/09627286.24.3.327 [DOI] [Google Scholar]
  • 41.Lilja-Maula L, Lappalainen AK, Hyytiäinen HK, Kuusela E, Kaimio M, Schildt K, et al. Comparison of submaximal exercise test results and severity of brachycephalic obstructive airway syndrome in English bulldogs. Vet J. 2017;219:22–6. doi: 10.1016/j.tvjl.2016.11.019 [DOI] [PubMed] [Google Scholar]
  • 42.Riggs J, Liu N, Sutton DR, Sargan D, Ladlow JF. Validation of exercise testing and laryngeal auscultation for grading brachycephalic obstructive airway syndrome in pugs, French bulldogs, and English bulldogs by using whole‐body barometric plethysmography. Vet Surg. 2019;48(4):488–96. doi: 10.1111/vsu.13159 [DOI] [PubMed] [Google Scholar]
  • 43.Marchant TW, Johnson EJ, McTeir L, Johnson CI, Gow A, Liuti T, et al. Canine brachycephaly is associated with a retrotransposon-mediated missplicing of SMOC2. Curr Biol. 2017;27(11):1573–1584.e6. doi: 10.1016/j.cub.2017.04.057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schoenebeck JJ, Hutchinson SA, Byers A, Beale HC, Carrington B, Faden DL, et al. Variation of BMP3 contributes to dog breed skull diversity. PLoS Genet. 2012;8(8):e1002849. doi: 10.1371/journal.pgen.1002849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Mansour TA, Lucot K, Konopelski SE, Dickinson PJ, Sturges BK, Vernau KL, et al. Whole genome variant association across 100 dogs identifies a frame shift mutation in DISHEVELLED 2 which contributes to Robinow-like syndrome in Bulldogs and related screw tail dog breeds. PLoS Genet. 2018;14(12):e1007850. doi: 10.1371/journal.pgen.1007850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Niskanen JE, Reunanen V, Salonen M, Bannasch D, Lappalainen AK, Lohi H. Canine DVL2 variant contributes to brachycephalic phenotype and caudal vertebral anomalies. Hum Genet. 2021;140(11):1535–45. doi: 10.1007/s00439-021-02261-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lilja-Maula LIO, Mäki KH, Aromaa MK, Rajamäki MM. Evaluation of brachycephalic obstructive airway syndrome breeding test results in Finland from 2017 to 2022. Acta Vet Scand. 2024;66(1):35. doi: 10.1186/s13028-024-00755-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sargan DR, Sargan D. The genetics of brachycephaly, population genetics and current health testing for brachycephalic breeds. Health and welfare of brachycephalic (flat-faced) companion animals: a complete guide for veterinary and animal professionals. 1st ed. Boca Raton: CRC Press; 2021. [Google Scholar]
  • 49.Falconer DS, Mackay TFC. Introduction to Quantitative Genetics. 4th ed. Pearson Education India; 1995. [Google Scholar]
  • 50.Laflamme DP. Development and validation of a body condition score system for dogs. Canine Pract. 1997;22(4):10–5. [Google Scholar]
  • 51.Meuwissen T, Luo Z. Computing inbreeding coefficients in large populations. Genet Sel Evol. 1992;24(4). doi: 10.1186/1297-9686-24-4-305 [DOI] [Google Scholar]
  • 52.Lee H, Craddock RF, Gorjanc G, Becher H. randPedPCA: rapid approximation of principal components from large pedigrees. Genet Sel Evol. 2025;57(1):46. doi: 10.1186/s12711-025-00994-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Butler DG, Cullis BR, Gilmour AR, Gogel BG, Thompson R. ASRemlR reference manual version 4.2. Hemel Hempstead, UK: VSN International Ltd.; 2023. [Google Scholar]
  • 54.Coster A. pedigree: Pedigree Functions [Internet]. 2009 [cited 2025 Oct 7]. Available from: https://CRAN.R-project.org/package=pedigree
  • 55.Raftery AE. Bayesian model selection in social research. Sociol Methodol. 1995;25:111. doi: 10.2307/271063 [DOI] [Google Scholar]
  • 56.The Royal Kennel Club. RFGS Breeding Recommendations [Internet]. 2024 [cited 2025 Oct 21]. Available from: https://www.thekennelclub.org.uk/health-and-dog-care/health/getting-started-with-health-testing-and-screening/respiratory-function-grading-scheme/#:~:text=them%20for%20breeding.-,Breeding%20advice,-For%20breeds%20where
  • 57.Young AI. Solving the missing heritability problem. PLOS Genet. 2019;15(6):e1008222. doi: 10.1371/journal.pgen.1008222 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Peng ZH, Ham KM, Ladlow J, Stefaniak C, Jeffery ND, Thieman Mankin KM. Comparison of remote and in‐person respiratory function grading of brachycephalic dogs. Vet Surg. 2025;54(3):573–80. doi: 10.1111/vsu.14171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Asher L, Buckland EL, Phylactopoulos CI, Whiting MC, Abeyesinghe SM, Wathes CM. Estimation of the number and demographics of companion dogs in the UK. BMC Vet Res. 2011;7(1):74. doi: 10.1186/1746-6148-7-74 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ilska JJ, Ryan PB, Tolhurst DJ. Modern pedigree dogs in the United Kingdom Kennel Club: a journey through shifting population landscapes and demography. Companion Anim Health Genet. 2025;12(1). doi: 10.1186/s40575-025-00142-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Kennel Club updates RFG Scheme Crufts entry criteria. In: [Internet]. RKC Media Centre. 2025. Available: https://www.royalkennelclub.com/about-us/resources/media-centre/2025/october/kennel-club-updates-rfg-scheme-crufts-entry-criteria/
  • 62.Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, et al. A β-defensin mutation causes black coat color in domestic dogs. Science. 2007;318(5855):1418–23. doi: 10.1126/science.1147880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Schmutz SM, Berryere TG, Goldfinch AD. TYRP1 and MC1R genotypes and their effects on coat color in dogs. Mammalian Genome. 2002;13(7):380–7. doi: 10.1007/s00335-001-2147-2 [DOI] [PubMed] [Google Scholar]
  • 64.FCI Breed Standard 101 [Internet]. Federation Cynologique Internationale. 2023. Available from: https://www.fci.be/en/nomenclature/FRENCH-BULLDOG-101.html
  • 65.Erskine M. Brachycephalic obstructive airway syndrome: a respiratory review. Companion Anim. 2024;29(6):62–70. doi: 10.12968/coan.2024.0008 [DOI] [Google Scholar]
  • 66.Nielen ALJ, Janss LLG, Knol BW. Heritability estimations for diseases, coat color, body weight, and height in a birth cohort of Boxers. Am J Vet Res. 2001;62(8). doi: 10.2460/ajvr.2001.62.1198 [DOI] [PubMed] [Google Scholar]
  • 67.Strandberg E, Andersson L, Emanuelson U, Bjørnvad CR, Ringmark S, Hedhammar Å. Heritability and genetic trend of body weight in dogs of different breeds in Sweden. J Anim Sci. 2023;101:skad173. doi: 10.1093/jas/skad173 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.German AJ, Holden SL, Morris PJ, Biourge V. Long-term follow-up after weight management in obese dogs: The role of diet in preventing regain. Vet J. 2012;192(1):65–70. doi: 10.1016/j.tvjl.2011.04.001 [DOI] [PubMed] [Google Scholar]
  • 69.Söder J, Roman E, Berndtsson J, Lindroth K, Bergh A. Effects of a physical exercise programme on bodyweight, body condition score and chest, abdominal and thigh circumferences in dogs. BMC Vet Res. 2024;20(1):299. doi: 10.1186/s12917-024-04135-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Bjørnvad CR, Gloor S, Johansen SS, Sandøe P, Lund TB. Neutering increases the risk of obesity in male dogs but not in bitches — A cross-sectional study of dog- and owner-related risk factors for obesity in Danish companion dogs. Prev Vet Med. 2019;170:104730. doi: 10.1016/j.prevetmed.2019.104730 [DOI] [PubMed] [Google Scholar]
  • 71.Wallis NJ, McClellan A, Mörseburg A, Kentistou KA, Jamaluddin A, Dowsett GKC, et al. Canine genome-wide association study identifies DENND1B as an obesity gene in dogs and humans. Science. 2025;387(6741):eads2145. doi: 10.1126/science.ads2145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Dimopoulou M, Engdahl K, Ladlow J, Andersson G, Hedhammar Å, Skiöldebrand E, et al. The epidemiology of upper respiratory tract disorders in a population of insured Swedish dogs (2011–2014), and its association to brachycephaly. Sci Rep. 2023;13(1):8765. doi: 10.1038/s41598-023-35466-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Pratschke K. Current thinking about brachycephalic syndrome: more than just airways. Companion Anim. 2014;19(2):70–8. doi: 10.12968/coan.2014.19.2.70 [DOI] [Google Scholar]
  • 74.Rujirekasuwan N, Sattasathuchana P, Theerapan W, Thengchaisri N. Comparative analysis of ocular biometry, ocular protrusion, and palpebral fissure dimensions in brachycephalic and nonbrachycephalic dog breeds. Vet Radiol Ultrasound. 2024;65(4):437–46. doi: 10.1111/vru.13351 [DOI] [PubMed] [Google Scholar]
  • 75.Milne E, Nuttall T, Marioni‐Henry K, Piccinelli C, Schwarz T, Azar A. Cytological and microbiological characteristics of middle ear effusions in brachycephalic dogs. J Vet Intern Med. 2020;34(4):1454–63. doi: 10.1111/jvim.15792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Reeve EJ, Sutton D, Friend EJ, Warren‐Smith CMR. Documenting the prevalence of hiatal hernia and oesophageal abnormalities in brachycephalic dogs using fluoroscopy. J Small Anim Pract. 2017;58(12):703–8. doi: 10.1111/jsap.12734 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Adolfo Maria Tambella

12 Feb 2026

Dear Dr. Ilska,

Please submit your revised manuscript by Mar 28 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols....

We look forward to receiving your revised manuscript.

Kind regards,

Adolfo Maria Tambella, DVM, MSc

Academic Editor

PLOS One

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

3. In the online submission form, you indicated that [The pedigree records and RFGS results of individual dogs registered with the Royal Kennel Club, are available on reasonable request in anonymised format].

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #1: Ilska et al. have studied three dog breeds susceptible to Brachycephalic Obstructive Airway Syndrome (BOAS). Using pedigrees and phenotype data, they have characterised these dog breeds and have estimated the breed-specific heritabilites for BOAS. This is a well-written original study, providing evidence on which future policies or breeding decisions may be based. I think this manuscript is suitable for publication. I have only a few comments.

General comments

Levels of genetic differentiation from PCA plots: I am delighted that Ilska and colleagues used our package for pedigree PCA. I would like to point out that ‘fanning out’ over time is a common observation when the founders of a pedigree are assumed to be unrelated. See fig. 1 (bottom-left panel) of our paper (Lee et al. 2025). On its own, this is not evidence for an increasing genetic differentiation. But it also does not preclude the possibility of increasing differentiation. To assess genetic differentiation from a pedigree, it might be more useful to compare the distributions of expected relationships between the coat colour groups from the pedigree A matrix. This could be done in time slices.

The main outcome of this work is the heritably estimated for BOAS. This is good and important. But I think it would be important to discuss potential biases to these estimates. E.g. Do litter mates share a common environment which may cause upward bias to h^2 estimates? Also, BOAS is linked to BCS, and BCS may be similar between relatives if these share the same environment?

At the same time there may be too low reporting of BOAS, or perhaps BOAS may only be detected of a dog is presented for other reasons. May this cause a downward bias to h^2 estimates.

Specific

• P10L225 data need not be normally distributed. The residuals in least-squares regression analyses should be. The effect is the same though. Much of the data are not continuous/they are ordinal. Nonparametric approaches as they were mainly used are other the better choice here.

• L235 number of litters is discrete, two-sample Wilcoxon test might perhaps be more appropriate than t-test here?

• L452 Perhaps better ‘Heredity estimation’ or similar? Better to describe section content rather than the method used

• L492 Perhaps better ‘Genetic correlations’ or similar?

Reviewer #2: Comments to Authors: Ilska, et al., provide a very important paper analyzing the largest (to date) dataset of RFGS data. The Respiratory Function Grading Scheme was established to objectively characterize individual dogs’ level of clinical signs associated with Brachycephalic Obstructive Airway Syndrome, which is of high concern due to its welfare impacts on dogs. The paper is timely and very well-written. They have calculated heritability estimates for RFGS grade and nostril stenosis, and with their data have been able to draw numerous interesting conclusions, some of which are a bit tangential but still fascinating, including the fact that so many dogs in the UK do not conform to breed standards, that participation in health testing is higher in dogs linked to confirmation-show lines (which means that “pet” breeders are not participating as much!), and others. Their data helps clarify the scope of breeding recommendations within the RFGS scale and even points to modifying the selection strategies (targeting multiple of these phenotypes at once can create more simultaneous progress). The paper was delightful to read and only needs a few relatively minor changes.

• There is some concern that the authors indicate that they will not make their data fully available; this does not seem to comply with journal policy. If the pedigrees are only provided in an anonymized format, will they even be useful to other researchers? I’m not certain if this would fall into the PLOS “rare exceptions” category under their Data Availability policy.

o I also wonder if the “custom Fortran 90 program” (line 210) is shareable?

• Lines 143-147: are the “two currently available estimates of heritability” for BOAS (as a phenotype)? Or for some other phenotype?

o The data from these two mentioned studies should be included as an additional paragraph in your discussion, comparing/contrasting with your own present findings. Furthermore, it is important to at least mention the fact that your heritability calculations are pedigree based, whereas the Sargan 2021 group used genetic data (although only from 200 dogs). SNP-based heritability is typically expected to yield lower heritabilities, due to missing rare variants, and pedigree-based methods (relying on assumed genetic sharing, e.g., 50% for full siblings) ignores that actual sharing can vary due to random segregation. The latter (pedigree-based heritabilities) are also subject to pedigree errors, which we all know happen more frequently than anyone would like to admit in dogs. Therefore, an entire paragraph should be added to the discussion explaining these pros/cons, and comparing the strengths/weaknesses of the present data to those other previously published studies. Given all of the above, it would also be interesting to have the authors speculate on why their heritability estimates are actually LOWER than the one existing SNP-based heritability estimate? (It could be that this cannot be done, as I’m not sure the Sargan 2021 publication had all the needed details?). Finally, the paragraph can wrap with a suggestion that, ideally, future work would have thousands of phenotyped samples, as in your study, that ALSO had genome-wide data, where both pedigree and actual genetic data could be combined, for a hopefully even more accurate estimate.

• Figure 3 (the histogram of body weight and body condition score) is not actually referred to anywhere in the text? And line 428, which calls out Figure 3…I think this should say Figure 4?

• Not an issue, but I just want to say that the PCA plots by birth year (Supps 4-6) are SO COOL!

• Table 5: What does the bolding indicate on this table? I think it’s to do with the p-values being less than 0.05, but this should be indicated in the table legend.

• On both Table 6 and Table S6, can you please include in the table legend what the greyed boxes indicate? I think those are your “diagonal cells”, but this should just be made clear.

• Line 675: it would probably be best to add “nostril” before the word stenosis here. I know you’re talking about nostril stenosis throughout the manuscript…but since other things can be stenotic, it’s better to just be abundantly clear.

• Line 686: Please change “symptoms” to “clinical signs”. Since symptoms are something that needs to be communicated with words (e.g., my head hurts, I feel very nauseated), none of our veterinary patients (or human pediatric patients, for that matter) can ever have symptoms. We can only measure and observe clinical signs in patients that cannot speak.

Reviewer #3: Thank you for an interesting and large heritability analysis of BOAS traits. This manuscript is well written and well thought through. I don't have much to recommend! It was readable, pertinent to our patients, and interesting.

The only big comment I have about the manuscript is the word "genetic" in the title. While this is true because we're talking about heritability, I think that many people will assume genomic sequencing rather than evaluation through pedigree- I did! I think that this one change (in the title) will set reader expectations.

In Table 6- please state what the shading indicates.

thanks for an interesting study!

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 May 13;21(5):e0348023. doi: 10.1371/journal.pone.0348023.r002

Author response to Decision Letter 1


16 Mar 2026

We thank the Reviewers for the positive reception of the manuscript and for the constructive feedback. Our point-by-point responses to their comments are outlined below. The line numbers noted below refer to the “paper post review with tracked changes.docx”.

Reviewer 1

"Ilska et al. have studied three dog breeds susceptible to Brachycephalic Obstructive Airway Syndrome (BOAS). Using pedigrees and phenotype data, they have characterised these dog breeds and have estimated the breed-specific heritabilites for BOAS. This is a well-written original study, providing evidence on which future policies or breeding decisions may be based. I think this manuscript is suitable for publication. I have only a few comments.

General comments:

Levels of genetic differentiation from PCA plots: I am delighted that Ilska and colleagues used our package for pedigree PCA. I would like to point out that ‘fanning out’ over time is a common observation when the founders of a pedigree are assumed to be unrelated. See fig. 1 (bottom-left panel) of our paper (Lee et al. 2025). On its own, this is not evidence for an increasing genetic differentiation. But it also does not preclude the possibility of increasing differentiation. To assess genetic differentiation from a pedigree, it might be more useful to compare the distributions of expected relationships between the coat colour groups from the pedigree A matrix. This could be done in time slices."

We thank the reviewer for underlining the possibility of the fanning out being due to founders being included in pedigree. We have now included this caveat in the manuscript in lines 443 - 445. However, the separation observed in our data was not solely temporal. This is supported by dogs from different coat colour groups clustering together, as well as strong association between testing participants and show breeding, which support the hypothesis of emerging substructure, rather than a purely generational artefact.

"The main outcome of this work is the heritably estimated for BOAS. This is good and important. But I think it would be important to discuss potential biases to these estimates. E.g. Do litter mates share a common environment which may cause upward bias to h^2 estimates? Also, BOAS is linked to BCS, and BCS may be similar between relatives if these share the same environment? At the same time there may be too low reporting of BOAS, or perhaps BOAS may only be detected of a dog is presented for other reasons. May this cause a downward bias to h^2 estimates. "

Following the comments of Reviewers 1 and 2, we have expanded on the impact that under-representation of affected individuals may have on the estimates of heritability (lines 600-609).

At present, our dataset contains few phenotyped littermates, which precluded inclusion of a litter effect in the model. We intend to revisit this as additional data become available, allowing more comprehensive modelling of common environmental influences, including litter and potential maternal effects. However, we do not anticipate that such effects would substantially influence the traits analysed here. RFGS is assessed in adult dogs, well after weaning, and in contrast to livestock, related dogs rarely share a long-term environment, as puppies are typically rehomed at 8–12 weeks of age. Consequently, persistent shared environmental effects among relatives are expected to be limited.

Specific

• P10L225 data need not be normally distributed. The residuals in least-squares regression analyses should be. The effect is the same though. Much of the data are not continuous/they are ordinal. Nonparametric approaches as they were mainly used are other the better choice here.

We have amended the wording in lines 226-227, describing the traits as ordinal.

• L235 number of litters is discrete, two-sample Wilcoxon test might perhaps be more appropriate than t-test here?

We have opted for t-test with unequal variances (Welch test) due to unequal variances and unequal sample sizes, which were both present in our data, and which can lead to increase in Type I error rate under Wilcoxon test.

• L452 Perhaps better ‘Heredity estimation’ or similar? Better to describe section content rather than the method used

We have changed the heading to Genetic parameters of RFGS grade (line 469)

• L492 Perhaps better ‘Genetic correlations’ or similar?

We have changed the heading to Correlations Between RFGS grade and Conformation Traits (line 515).

Reviewer 2:

"Comments to Authors: Ilska, et al., provide a very important paper analyzing the largest (to date) dataset of RFGS data. The Respiratory Function Grading Scheme was established to objectively characterize individual dogs’ level of clinical signs associated with Brachycephalic Obstructive Airway Syndrome, which is of high concern due to its welfare impacts on dogs. The paper is timely and very well-written. They have calculated heritability estimates for RFGS grade and nostril stenosis, and with their data have been able to draw numerous interesting conclusions, some of which are a bit tangential but still fascinating, including the fact that so many dogs in the UK do not conform to breed standards, that participation in health testing is higher in dogs linked to confirmation-show lines (which means that “pet” breeders are not participating as much!), and others. Their data helps clarify the scope of breeding recommendations within the RFGS scale and even points to modifying the selection strategies (targeting multiple of these phenotypes at once can create more simultaneous progress). The paper was delightful to read and only needs a few relatively minor changes.

• There is some concern that the authors indicate that they will not make their data fully available; this does not seem to comply with journal policy. If the pedigrees are only provided in an anonymized format, will they even be useful to other researchers? I’m not certain if this would fall into the PLOS “rare exceptions” category under their Data Availability policy."

We provide the data where the phenotypes and associated variables can be matched to anonymised pedigree in the supplementary materials. This would enable researchers to repeat our analysis, and/or apply different models to the data.

• I also wonder if the “custom Fortran 90 program” (line 210) is shareable?

The analyses were conducted using a custom Fortran program developed for internal use, optimised for the data structures used in RKC database. The code is not currently available for distribution, but its functionality can be found in other, publicly available software packages.

• Lines 143-147: are the “two currently available estimates of heritability” for BOAS (as a phenotype)? Or for some other phenotype?

We have added that it is heritability of BOAS.

• The data from these two mentioned studies should be included as an additional paragraph in your discussion, comparing/contrasting with your own present findings. Furthermore, it is important to at least mention the fact that your heritability calculations are pedigree based, whereas the Sargan 2021 group used genetic data (although only from 200 dogs). SNP-based heritability is typically expected to yield lower heritabilities, due to missing rare variants, and pedigree- based methods (relying on assumed genetic sharing, e.g., 50% for full siblings) ignores that actual sharing can vary due to random segregation. The latter (pedigree-based heritabilities) are also subject to pedigree errors, which we all know happen more frequently than anyone would like to admit in dogs. Therefore, an entire paragraph should be added to the discussion explaining these pros/cons, and comparing the strengths/weaknesses of the present data to those other previously published studies. Given all of the above, it would also be interesting to have the authors speculate on why their heritability estimates are actually LOWER than the one existing SNP-based heritability estimate? (It could be that this cannot be done, as I’m not sure the Sargan 2021 publication had all the needed details?). Finally, the paragraph can wrap with a suggestion that, ideally, future work would have thousands of phenotyped samples, as in your study, that ALSO had genome-wide data, where both pedigree and actual genetic data could be combined, for a hopefully even more accurate estimate.

We have now expanded on our comparison to the Finnish study (lines 596 – 611), and added a paragraph comparing our estimates to those of Sargan (2021) (lines 617 - 624). Unfortunately, lack of details in Sargan (2021) makes drawing any firm conclusions impossible.

• Figure 3 (the histogram of body weight and body condition score) is not actually referred to anywhere in the text? And line 428, which calls out Figure 3…I think this should say Figure 4?

Thank you for spotting this. Figure 3 is referred to in lines 408 and 410, previously erroneously citing Figure 4. Line 438 was corrected to Figure 4.

• Not an issue, but I just want to say that the PCA plots by birth year (Supps 4-6) are SO COOL!

Thank you – we were very excited to see those too!

• Table 5: What does the bolding indicate on this table? I think it’s to do with the p-values being less than 0.05, but this should be indicated in the table legend.

Reviewer is correct, bolding indicates statistically significant effects. We have added the explanation in the table legend.

• On both Table 6 and Table S6, can you please include in the table legend what the greyed boxes indicate? I think those are your “diagonal cells”, but this should just be made clear.

We have corrected the legends as suggested.

• Line 675: it would probably be best to add “nostril” before the word stenosis here. I know you’re talking about nostril stenosis throughout the manuscript…but since other things can be stenotic, it’s better to just be abundantly clear.

We have added “nostril” as suggested (line 742).

• Line 686: Please change “symptoms” to “clinical signs”. Since symptoms are something that needs to be communicated with words (e.g., my head hurts, I feel very nauseated), none of our veterinary patients (or human pediatric patients, for that matter) can ever have symptoms. We can only measure and observe clinical signs in patients that cannot speak.

We have amended this as suggested (line 753).

Reviewer #3:

Thank you for an interesting and large heritability analysis of BOAS traits. This manuscript is well written and well thought through. I don't have much to recommend! It was readable, pertinent to our patients, and interesting. The only big comment I have about the manuscript is the word "genetic" in the title. While this is true because we're

talking about heritability, I think that many people will assume genomic sequencing rather than evaluation through pedigree- I did! I think that this one change (in the title) will set reader expectations.

We have amended the title from “Genetic variation” to “Quantitative genetic analysis”, as we agree with Reviewer’s comment on setting appropriate expectation for the reader.

In Table 6- please state what the shading indicates.

Thank you – we have amended the legends for Table 6 and S6.

thanks for an interesting study!

Attachment

Submitted filename: Response to reviewers.docx

pone.0348023.s015.docx (22.8KB, docx)

Decision Letter 1

Adolfo Maria Tambella

10 Apr 2026

Quantitative genetic analysis of respiratory function and related traits in Bulldogs, French Bulldogs and Pugs

PONE-D-25-67266R1

Dear Dr. Ilska,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support....

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Adolfo Maria Tambella, DVM, MSc

Academic Editor

PLOS One

Additional Editor Comments (optional):

The manuscript has been entirely and carefully revised. The current version can be considered suitable for publication in PLoS ONE. Congratulations to the authors!

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.-->

Reviewer #1: No

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #3: Yes

**********

Reviewer #1: (No Response)

Reviewer #3: Thanks for the changes. It looks good. Was the legend to table 6 updated - maybe I missed this since you said you did it in the response? Please include what the grey cells mean. In table 5, please include what the bold means.

**********

what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..-->

Reviewer #1: No

Reviewer #3: No

**********

Acceptance letter

Adolfo Maria Tambella

PONE-D-25-67266R1

PLOS One

Dear Dr. Ilska,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Adolfo Maria Tambella

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Details of the respiratory function grading scheme.

    (DOCX)

    pone.0348023.s001.docx (18.4KB, docx)
    S2 File. Preliminary estimation of heritability of RFGS Grade using parent offspring regression.

    (DOCX)

    pone.0348023.s002.docx (15.1KB, docx)
    S1 Fig. PCA plot of Bulldog population, stratified by year of birth and coat colour group.

    (GIF)

    pone.0348023.s003.gif (925.8KB, gif)
    S2 Fig. PCA plot of French Bulldog population, stratified by year of birth and coat colour group.

    (GIF)

    pone.0348023.s004.gif (769.5KB, gif)
    S3 Fig. PCA plot of Pug population, stratified by year of birth and coat colour group.

    (GIF)

    S1 Table. Coat colours in the three breeds divided into breed standard, and non-breed standard.

    (XLSX)

    pone.0348023.s006.xlsx (24.7KB, xlsx)
    S2 Table. Residual and assessor effect correlation between traits used in multivariate analyses.

    (DOCX)

    pone.0348023.s007.docx (15.9KB, docx)
    S3 Table. Pedigree for Bulldog.

    (CSV)

    pone.0348023.s008.csv (17.5MB, csv)
    S4 Table. Pedigree for French Bulldog.

    (CSV)

    pone.0348023.s009.csv (33.6MB, csv)
    S5 Table. Pedigree for Pug.

    (CSV)

    pone.0348023.s010.csv (13.4MB, csv)
    S6 Table. Phenotypes for Bulldog.

    (CSV)

    pone.0348023.s011.csv (127.3KB, csv)
    S7 Table. Phenotypes for French Bulldog.

    (CSV)

    pone.0348023.s012.csv (167.4KB, csv)
    S8 Table. Phenotypes for Pug.

    (CSV)

    pone.0348023.s013.csv (75.8KB, csv)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0348023.s015.docx (22.8KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES